MedTrace Logo

CoolSculpting Treatment in the Upper Arms

NCT02939105 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-06-09

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using specialized vacuum applicators for non-invasive subcutaneous fat reduction of the upper arms.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The ZELTIQ CoolSculpting System

The CoolSculpting device will be used to perform treatments.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Principal Investigators

  • Jason Rivers, MD · Pacific Dermaesthetics

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-02
Primary Completion
2017-03-03
Completion
2017-03-03
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02939105 on ClinicalTrials.gov